Lidocaine Hydrochloride Jelly
Product Images NDC 0404-9900
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0404-9900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
This text provides assembly directions for a ringe (or syringe). It emphasizes the use of aseptic technique and advises against assembling the syringe until it is ready to be used. The instructions include opening a sterile pouch, dropping the contents onto a sterile field, threading a vial into an injector, turning the vial half way, removing the cap, and expelling air. The text warns against pushing the vial into the injector to avoid misalignment.*
Image2.jpg (Image2)
Label1.jpg (Label1)
This is a description for Lidocaine HCL Jelly 2% in a 100mg package. This jelly is for topical use only and there is no preservative added. It is a local anesthetic, and it is recommended for single-use with sterile aseptic technique. It is advised not to open the package until ready to use. The package should be stored at a controlled temperature between 59°F to 86°F. The package contains 5m sterile Pak Uro-Jet, and the manufacturer's insert should be consulted for complete product and prescribing information. The product was packaged by Henry Schein, Inc. It is not clear what the item # refers to. The LOT# (XXXX) is also provided, along with the GTIN number and SER#.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.